High expression of LIMD2 predicts a poor prognosis and promotes migration of colon cancer cells
Our findings indicate that LIMD2 serves as a novel prognostic biomarker and potential target for colon cancer treatment.
Authors
- Wanjun Xu (ORCID: https://orcid.org/0000-0003-1023-4671)
- Fengjuan Cai
- Dongdong Li (ORCID: https://orcid.org/0000-0002-1880-8054)
- Xiaoyan Wang (ORCID: https://orcid.org/0000-0002-6891-5560)
- Jianjun Wang (ORCID: https://orcid.org/0000-0002-6800-3000)
- Xiaomin Li
- Guodong Liu (ORCID: https://orcid.org/0000-0002-9748-9556)
- Yu Wang (ORCID: https://orcid.org/0000-0001-7894-6523)
- Yujie Cai
- Jingtao Zhang
Institutions
- Wannan Medical College (CN)
- Xuzhou Medical College (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1007/s12672-025-03424-z
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00